• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Vytorin (ezetimibe/simvastatin) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – November 2009

 

Summary View

 

ADVERSE REACTIONS

Post-Marketing Experience
  • erythema multiforme

PATIENT PACKAGE INSERT

What are the possible side effects of Vytorin?
  • Raised red rash, sometimes with target-shaped lesions